# SVT-15652 Otic Solution for the Treatment of Otomycosis.

> **NCT03686397** · PHASE3 · COMPLETED · sponsor: **Salvat** · enrollment: 194 (actual)

## Conditions studied

- Otomycosis

## Interventions

- **DRUG:** SVT-15652
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03686397
- **Lead sponsor:** Salvat
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-09
- **Primary completion:** 2021-10-19
- **Final completion:** 2021-10-19
- **Target enrollment:** 194 (ACTUAL)
- **Last updated:** 2022-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03686397

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03686397, "SVT-15652 Otic Solution for the Treatment of Otomycosis.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03686397. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*